Gene · 3977
Papers2,592
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,592
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SUCLG2 Regulates Mitochondrial Dysfunction through Succinylation in Lung Adenocarcinoma. | Adv Sci (Weinh) | 2023 | 37904651 | PubTator, text mining | PubMed |
| Role of Interleukin-6 Family Cytokines in Organ Fibrosis. | Kidney Dis (Basel) | 2023 | 37900004 | PubTator, text mining | PubMed |
| Hydrogel-Based Therapeutics for Pancreatic Ductal Adenocarcinoma Treatment. | Pharmaceutics | 2023 | 37896181 | PubTator, text mining | PubMed |
| Heterogeneity in the Metastatic Microenvironment: JunB-Expressing Microglia Cells as Potential Drivers of Melanoma Brain Metastasis Progression. | Cancers (Basel) | 2023 | 37894348 | PubTator, text mining | PubMed |
| Profound DNA methylomic differences between single- and multi-fraction alpha irradiations of lung fibroblasts. | Clin Epigenetics | 2023 | 37891670 | PubTator, text mining | PubMed |
| Letrozole-stimulated endometrial preparation protocol is a superior alternative to hormone replacement treatment for frozen embryo transfer in women with polycystic ovary syndrome, a cohort study. | Reprod Biol Endocrinol | 2023 | 37891650 | PubTator, text mining | PubMed |
| Molecular mechanisms in colitis-associated colorectal cancer. | Oncogenesis | 2023 | 37884500 | PubTator, text mining | PubMed |
| Tumor microenvironment-dependent epigenetic imprinting in the vasculature predicts colon cancer outcome. | Cancer Commun (Lond) | 2023 | 37859581 | PubTator, text mining | PubMed |
| Single-cell characterization of self-renewing primary trophoblast organoids as modeling of EVT differentiation and interactions with decidual natural killer cells. | BMC Genomics | 2023 | 37853336 | PubTator, text mining | PubMed |
| Lung Cancer Organoids as Avatars of Patients With Lung Cancer in the Prediction of Therapeutic Response. | JTO Clin Res Rep | 2023 | 37842325 | PubTator, text mining | PubMed |
| The clinical relevance of OSM in inflammatory diseases: a comprehensive review. | Front Immunol | 2023 | 37841259 | PubTator, text mining | PubMed |
| Effect of Continuous Ingestion of Bifidobacteria and Dietary Fiber on Improvement in Cognitive Function: A Randomized, Double-Blind, Placebo-Controlled Trial. | Nutrients | 2023 | 37836458 | PubTator, text mining | PubMed |
| Pancreatic Cancer-Secreted Proteins: Targeting Their Functions in Tumor Microenvironment. | Cancers (Basel) | 2023 | 37835519 | PubTator, text mining | PubMed |
| Age-related influence on DNA damage, proteomic inflammatory markers and oxidative stress in hospitalized COVID-19 patients compared to healthy controls. | Redox Biol | 2023 | 37832397 | PubTator, text mining | PubMed |
In Cerebellar Atrophy of 12-Month-Old ATM-Null Mice, Transcriptome Upregulations Concern Most Neurotransmission and Neuropeptide Pathways, While Downregulations Affect Prominently Itpr1, Usp2 and Non-Coding RNA. | Cells | 2023 | 37830614 | PubTator, text mining | PubMed |
| Empagliflozin Reverses Oxidized LDL-Induced RECK Suppression, Cardiotrophin-1 Expression, MMP Activation, and Human Aortic Smooth Muscle Cell Proliferation and Migration. | Mediators Inflamm | 2023 | 37830075 | PubTator, text mining | PubMed |
| Hyperuricemia remodels the serum proteome toward a higher inflammatory state. | iScience | 2023 | 37810213 | PubTator, text mining | PubMed |
| Ferroptosis, autophagy, tumor and immunity. | Heliyon | 2023 | 37810047 | PubTator, text mining | PubMed |
| Identification of key genes associated with poor prognosis and neoplasm staging in gastric cancer. | Medicine (Baltimore) | 2023 | 37800754 | PubTator, text mining | PubMed |
| Discovery of Novel Fedratinib-Based HDAC/JAK/BRD4 Triple Inhibitors with Remarkable Antitumor Activity against Triple Negative Breast Cancer. | J Med Chem | 2023 | 37796543 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3977/papers?page=14